PYC Therapeutics Limited (ASX:PYC)

PYC Therapeutics Revenue

In the fiscal year ending June 30, 2026, PYC Therapeutics had annual revenue of 25.99M AUD with 10.64% growth. PYC Therapeutics had revenue of 17.09M in the half year ending June 30, 2026, with 29.96% growth.

• Revenue: 25.99M
• Revenue Growth: +10.64%
• P/S Ratio: 90.81
• Revenue / Employee: 5.20M
• Employees: 5
• Market Cap: 2.36B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	25.99M	2.50M	10.64%
Jun 30, 2025	23.49M	1.44M	6.51%
Jun 30, 2024	22.06M	6.25M	39.56%
Jun 30, 2023	15.81M	-236.57K	-1.47%
Jun 30, 2022	16.04M	12.97M	421.83%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 15, 2026

Data Sources Report a data error